Everest Re Group, Ltd. (EG)

FairStock Score: 71/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Everest Re is a reinsurer and specialty insurer, a business I can understand but one where underwriting discipline matters more than story. The figures show a mixed but not broken picture. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $4.0B, net income $559.0M, and diluted EPS $14.22. That compares with fiscal Q2 2025 revenue of $4.5B, net income of $680.0M, and EPS of $16.10—so sales and earnings fell year over year. For full fiscal 2025, revenue was $17.5B and net income $1.6B, up from $17.3B and $1.4B in fiscal 2024, but fiscal 2023 net income was much higher at $2.5B. Consistency is not perfect. At the 2026-10-26 close of $397.61, FairStock calculates 8.4 times EPS, 1.0 times book, a 12.57% ROE, and D/E of 0.23. That looks statistically cheap for a low-beta, dividend-paying reinsurer, and the FairStock score is 71/100. But the Piotroski F-score is 3/9, warning that recent accounting signals are weak. I do not have CET1 or NIM—not meaningful for an insurer—nor the combined ratio, reserve development, or catastrophe-loss data needed to judge underwriting quality. The Lynch category is FAST GROWER on five-year profit and revenue growth, yet the latest filed quarter is shrinking. I would call this a reasonably priced cyclical financial with a margin of safety only if reserves are adequate.

In plain English: Everest Re sells insurance and reinsurance to other insurers and businesses. It earned solid profits in the first half of 2026, but recent quarterly sales and profit fell from a year earlier, and earnings have been uneven. The stock price looks cheap to fair compared with its profits and net assets.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer